Cancer Clinical Investigators Should Converge with Pharmacometricians

被引：3
|
作者：
Maitland, Michael L. [1 ,2 ]
O'Cearbhaill, Roisin E. [3 ,4 ]
Gobburu, Jogarao [5 ]
机构：
[1] Inova Schar Canc Inst, 3289 Woodburn Rd, Annandale, VA 22003 USA
[2] Univ Virginia, Annandale, VA USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
[5] Univ Maryland, Sch Pharm, Ctr Translat Med, Baltimore, MD 21201 USA
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 17期
关键词：
D O I：
10.1158/1078-0432.CCR-19-1067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The applied quantitative science pharmacometrics has significantly enhanced cancer therapeutics development. Pharmacometrics is now improving our understanding of complex diagnostics. Through the concept of convergence and methods of quantitative and systems pharmacology, pharmacometrics is poised to interconnect mathematical models of disease and therapy to advance cancer care.
引用
收藏
页码：5182 / 5184
页数：3
相关论文
共 50 条
  • [41] TOWARD AN ADEQUATE POOL OF CLINICAL INVESTIGATORS
    SHERMAN, JF
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 1980, 23 (02) : S79 - S82
  • [42] Overview of Basic Immunology for Clinical Investigators
    Stephen, Bettzy
    Hajjar, Joud
    IMMUNOTHERAPY, 2017, 995 : 1 - 31
  • [43] Clinical investigators and the pharmaceutical industry - Reply
    Bodenheimer, T
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07): : 511 - 511
  • [44] Clinical investigators - The endangered species revisited
    Miller, ED
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (07): : 845 - 846
  • [45] WHENCE COMETH TOMORROWS CLINICAL INVESTIGATORS
    DIBONA, GF
    CLINICAL RESEARCH, 1979, 27 (03): : 253 - 256
  • [46] HORIZONS OF CLINICAL RESEARCH, OR WHO ARE THE TRUE CLINICAL INVESTIGATORS
    DELEON, SP
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1986, 38 (01): : 115 - 116
  • [47] A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop
    Von Hoff, Daniel D.
    Clark, Gary M.
    Coltman, Charles A.
    Disis, Mary L.
    Eckhardt, S. G.
    Ellis, Lee M.
    Foti, Margaret
    Garrett-Mayer, Elizabeth
    Gonen, Mithat
    Hidalgo, Manuel
    Hilsenbeck, Susan G.
    Littlefield, John H.
    LoRusso, Patricia M.
    Lyerly, H. Kim
    Meropol, Neal J.
    Patel, Jyoti D.
    Piantadosi, Steven
    Post, Dean A.
    Regan, Meredith M.
    Shyr, Yu
    Tempero, Margaret A.
    Tepper, Joel E.
    Von Roenn, Jamie
    Weiner, Louis M.
    Young, Donn C.
    Vu, Nu V.
    CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5472 - 5481
  • [48] Patterns of nest usurpation: When should species converge on nest niches?
    Lindell, C
    CONDOR, 1996, 98 (03): : 464 - 473
  • [49] COMMENTARY: INVESTIGATORS SHOULD/SHOULD NOT CONTROL FOR MENSTRUAL CYCLE PHASEWHEN PERFORMING STUDIES OF VASCULAR CONTROL THAT INCLUDEWOMEN
    Wickham, Kate A.
    JOURNAL OF APPLIED PHYSIOLOGY, 2020, 129 (05) : 1133 - 1134
  • [50] Should criteria for inclusion in cancer clinical trials be expanded?
    Gerber, David E.
    Pruitt, Sandi L.
    Halm, Ethan A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (04) : 289 - 291
12345